Primary graft dysfunction after liver transplantation: from pathogenesis to prevention.
Bzeizi
K I
KI
Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Scotland, UK.
Jalan
R
R
Plevris
J N
JN
Hayes
P C
PC
D016232:Endothelins / Q000502:physiology; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007728:Kupffer Cells / Q000502:physiology; D015289:Leukotrienes / Q000502:physiology; D008107:Liver Diseases / Q000209:etiology* / Q000473:pathology; D016031:Liver Transplantation / Q000009:adverse effects*; D009504:Neutrophils / Q000502:physiology; D009569:Nitric Oxide / Q000009:adverse effects; D009926:Organ Preservation / Q000009:adverse effects; D010972:Platelet Activating Factor / Q000502:physiology; D017382:Reactive Oxygen Species / Q000502:physiology; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control; D014019:Tissue Donors
D016232:Endothelins; D015289:Leukotrienes; D010972:Platelet Activating Factor; D017382:Reactive Oxygen Species; D009569:Nitric Oxide